NANOVIRICIDES, INC.(NNVC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
NNVC Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for NANOVIRICIDES, INC. (NNVC), a Healthcare sector company. NNVC is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q1 2026), NANOVIRICIDES, INC. reports net income of $-2.0M, free cash flow of $-1.9M. Top institutional holders of NNVC by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, Connective Capital Management, based on the most recent SEC filings. NNVC trades on the NYSE exchange and files with the SEC under CIK 1379006. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NNVC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NANOVIRICIDES, INC. directly from SEC EDGAR.
Revenue
Q1 2026
$0.00
Net Income
Q1 2026
$-2.0M
Free Cash Flow
Q1 2026
$-1.9M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
Net Income
-14.1% YoYOperating Income
-12.6% YoYEPS (Diluted)
+10.0% YoYTotal Assets
-31.2% YoYOp. Cash Flow
-34.3% YoYFree Cash Flow
-31.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — | — | — |
| Net Income | $-9.5M -14.1% | $-8.3M +3.4% | $-8.6M -5.9% | $-8.1M +8.1% | $-8.8M +34.4% | $-13.4M |
| Operating Income | $-9.6M -12.6% | $-8.5M +4.8% | $-8.9M -10.2% | $-8.1M +7.2% | $-8.7M -9.3% | $-8.0M |
| EPS (Diluted) | $-0.63 +10.0% | $-0.70 +5.4% | $-0.74 -5.7% | $-0.70 +13.6% | $-0.81 | — |
| Total Assets | $8.8M -31.2% | $12.8M -24.1% | $16.9M -28.1% | $23.5M -22.4% | $30.3M +26.5% | $23.9M |
| Operating Cash Flow | $-8.5M -34.3% | $-6.3M -11.4% | $-5.7M +3.8% | $-5.9M +28.3% | $-8.2M -23.2% | $-6.7M |
| Free Cash Flow | $-8.5M -31.9% | $-6.5M -11.2% | $-5.8M +6.3% | $-6.2M +26.5% | $-8.5M -26.6% | $-6.7M |
Get alerted when NNVC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for NANOVIRICIDES, INC. including:
Top Institutional Holders of NNVC
VANGUARD CAPITAL MANAGEMENT LLC
$1.3M919,313 shGEODE CAPITAL MANAGEMENT, LLC
$298.2K216,022 shConnective Capital Management, LLC
$255.6K185,217 shBlackRock, Inc.
$219.1K158,753 shVANGUARD FIDUCIARY TRUST CO
$182.1K131,923 shRENAISSANCE TECHNOLOGIES LLC
$177.5K128,600 shMiller Financial Services LLC
$154.6K112,000 shUBS Group AG
$137.1K99,331 shCreative Planning
$119.7K86,761 shCITADEL ADVISORS LLC
$100.7K73,000 sh
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.3M | 919,313 |
| GEODE CAPITAL MANAGEMENT, LLC | $298.2K | 216,022 |
| Connective Capital Management, LLC | $255.6K | 185,217 |
| BlackRock, Inc. | $219.1K | 158,753 |
| VANGUARD FIDUCIARY TRUST CO | $182.1K | 131,923 |
| RENAISSANCE TECHNOLOGIES LLC | $177.5K | 128,600 |
| Miller Financial Services LLC | $154.6K | 112,000 |
| UBS Group AG | $137.1K | 99,331 |
| Creative Planning | $119.7K | 86,761 |
| CITADEL ADVISORS LLC | $100.7K | 73,000 |
More Healthcare Companies
View all Healthcare →Put NNVC on your watchlist
Track score changes the day NANOVIRICIDES, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NNVC a good stock to buy?
13F Pro's AI-powered analysis of NANOVIRICIDES, INC. (NNVC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NNVC are available on the NNVC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NNVC is classified as a small company.
Which hedge funds own NNVC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NNVC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NANOVIRICIDES, INC.'s investment landscape.